On the Record · Phibro Animal Health
Phibro Animal Health competitors, on the record
The companies Phibro Animal Health itself names as competitors in its annual reports, 2024 to 2026, each with the sentence it appears in and the filing it came from.
Who Phibro Animal Health names
| Company | Named in |
|---|---|
| Boehringer Ingelheim International GmbH | 2026 |
| Ceva Santé Animale | 2026 |
| Elanco Animal Health Incorporated | 2026 |
| Huvepharma Inc. | 2026 |
| Merck & Co., Inc. | 2026 |
| Southeastern Minerals, Inc. | 2026 |
| Zoetis | 2026 |
In its own words
Boehringer Ingelheim International GmbH, Ceva Santé Animale, Elanco Animal Health Incorporated, Huvepharma Inc., Merck & Co., Inc., Southeastern Minerals, Inc., Zoetis
Word for word“Some of our principal competitors include Boehringer Ingelheim International GmbH, Ceva Santé Animale, Elanco Animal Health Incorporated, Huvepharma Inc., Merck & Co., Inc. (Merck Animal Health and MSD Animal Health), Southeastern Minerals, Inc. and Zoetis.” 10-K for 2026
Read from Phibro Animal Health’s annual reports (10-K for 2026, 10-K for 2025, 10-K for 2024) and the financial data it files with the SEC, as of 2026-08-26. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.